Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
TherapeuticsMD Inc.

Start price
Target price
Perf. (%)
€320.35
18.03.17
€600.00
27.09.17
-30.72%
27.09.17

buy
VERBIO Vereinigte BioEnergie AG

Start price
Target price
Perf. (%)
€10.70
17.03.17
€15.00
03.01.18
-23.80%
03.01.18

buy
NVIDIA Corp.

Start price
Target price
Perf. (%)
€0.61
17.03.17
€0.69
05.04.17
-3.65%
05.04.17

buy
Tronox Ltd. A

Start price
Target price
Perf. (%)
€15.09
17.03.17
€18.00
18.04.17
-3.43%
18.04.17

buy
NorCom Information Technology GmbH & Co. KGAA

Start price
Target price
Perf. (%)
€18.99
17.03.17
€87.50
02.10.19
-21.31%
02.10.19

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Growths much faster than the competition
Very Future proof/growth oriented business model
buy
PNE AG

Start price
Target price
Perf. (%)
€2.62
17.03.17
€2.99
18.09.17
1.18%
18.09.17

buy
Deutsche Bank AG

Start price
Target price
Perf. (%)
€18.03
16.03.17
€25.00
19.05.17
4.88%
19.05.17

buy
Deutsche Konsum REIT AG

Start price
Target price
Perf. (%)
€8.67
14.03.17
€9.54
15.09.17
4.62%
15.09.17

buy
Organigram Holdings Inc.

Start price
Target price
Perf. (%)
€6.64
14.03.17
€11.21
30.06.17
-11.07%
30.06.17

buy
Genmab A/S

Start price
Target price
Perf. (%)
€191.57
14.03.17
€210.00
14.09.17
1.07%
14.09.17

buy
Meta Platforms Inc.

Start price
Target price
Perf. (%)
€125.75
14.03.17
€135.30
24.03.17
0.88%
24.03.17

buy
GenVec Inc.

Start price
Target price
Perf. (%)
€6.51
11.03.17
€8.12
15.05.17
7.48%
15.05.17

buy
Tesla Inc

Start price
Target price
Perf. (%)
€14.81
10.03.17
€17.32
03.04.17
18.67%
03.04.17

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Very positive Cash Flow expected
buy
Neos Therapeutics Inc

Start price
Target price
Perf. (%)
€6.31
10.03.17
€10.10
26.10.17
44.29%
26.10.17

buy
Adler Real Estate AG

Start price
Target price
Perf. (%)
€12.80
09.03.17
€16.36
02.06.17
9.06%
02.06.17

buy
F-Star Therapeutics Inc.

Start price
Target price
Perf. (%)
€39.51
05.03.17
€86.59
06.09.17
37.53%
06.09.17

buy
Loxo Oncology Inc

Start price
Target price
Perf. (%)
€40.59
05.03.17
€45.10
05.06.17
62.16%
05.06.17

buy
Paratek Pharma

Start price
Target price
Perf. (%)
€14.25
02.03.17
€20.20
10.04.17
43.35%
10.04.17

Tesla Inc

Start price
Target price
Perf. (%)
€15.08
01.03.17
€3.01
04.01.18
25.67%
04.01.18

Revenue growth >5% per year expected
Risky Investment
overvalued
Very low/no dividend yield expected
buy
Credit Suisse Group AG

Start price
Target price
Perf. (%)
€14.82
01.03.17
€19.00
13.03.17
-2.67%
13.03.17

buy
Berkshire Hathaway Inc. B

Start price
Target price
Perf. (%)
€154.15
28.02.17
€167.77
28.08.17
4.65%
28.08.17

buy
Tronox Ltd. A

Start price
Target price
Perf. (%)
€16.11
28.02.17
€21.00
10.03.17
-7.12%
10.03.17

buy
NVIDIA Corp.

Start price
Target price
Perf. (%)
€0.61
28.02.17
€0.75
03.03.17
-4.68%
03.03.17

buy
Micron Technology Inc.

Start price
Target price
Perf. (%)
€21.27
27.02.17
€98.00
22.10.24
183.32%
22.07.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Undervalued
Low dividend yield expected
buy
7C Solarparken

Start price
Target price
Perf. (%)
€2.44
25.02.17
€2.55
18.09.17
-2.50%
18.09.17